作者：
Allison,Ross [1]
;
Philip J,Meacham [1]
;
J P,Waswa [2]
;
Mohan P,Joshi [3]
;
Tamara,Hafner [3]
;
Sarah,Godby [1]
;
Courtney,Johnson [1]
;
Shilpa,Londhe [1]
;
Dorothy,Aibo [2]
;
Grace,Kwikiriza [2]
;
Hassan,Kasujja [2]
;
Reuben,Kiggundu [2]
;
Michelle,Cho [1]
;
Sarah,Kovar [1]
;
Freddy Eric,Kitutu [4]
作者单位：
Deloitte Consulting LLP, Arlington, VA 22209, USA.
[1]
USAID Medicines, Technologies and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health (MSH), Kampala 920102, Uganda.
[2]
USAID Medicines, Technologies and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health (MSH), Arlington, VA 22203, USA.
[3]
Department of Pharmacy, School of Health Sciences, Makerere University, Kampala 920102, Uganda.;Antimicrobial Stewardship, Optimal Access and Use (ASO) Technical Working Committee, National One Health Platform, Kampala 920102, Uganda.
[4]
DOI
10.3390/antibiotics13111016
PMID
39596711
发布时间
2024-11-30
换一批
换一批
